Ines Batinic-Haberle

This inventor holds 25 USPTO granted patents and 7 published patent applications and 3 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Duke University, Aeolus Sciences, Inc., Biomimetix Jv, LLC. Active years: 2000-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ines Batinic-Haberle. Retrieved from https://idiyas.com/inventor/ines-batinic-haberle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25 (Patent Applications = 7)

% Patents Active = 52.0

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 196(Granted Patents)

Company Filing History:

Aeolus Sciences, Inc.

National Jewish Health

patents

5. 2 out of 41

National Jewish Medical and Research Center

patents

6. 1 out of 1

Aelous Pharmaceuticals, Inc.

patent

7. 1 out of 1

Aeolus Pharmaceuticals, Inc.

National Jewish Medical Research Center

patents

10. 3 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2000-2024

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Substituted Porphyrins

Cancer Therapy

Oxidant Scavengers

Fluorescent Staining

Radiation Exposure

Chemotherapy

Pruritus Treatment

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12171769 - Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure (2024-12-24),

2. 11344574 - Fluoro substituted porphyrin compounds, pharmaceutical compositions comprising the same, and methods of preparing and using the same (2022-05-31),

3. 11285162 - Methods, compositions, and kits for treating and/or preventing a side effect associated with radiation and/or chemotherapy exposure (2022-03-29),

4. 11065259 - Methods of treating pruritus (2021-07-20),

5. 10080759 - Methods of treating pruritus (2018-09-25),

6. 9289434 - Substituted porphyrins (2016-03-22),

7. 9096628 - Substituted porphyrins (2015-08-04),

8. 9034596 - Method for fluorescent staining of cellular and intracellular membranes (2015-05-19),

9. 8946202 - Substituted porphyrins (2015-02-03),

10. 8765729 - Cancer therapy (2014-07-01),

11. 8759324 - Method of activation of oxazaphosphorines (2014-06-24),

12. 8618089 - Substituted porphyrins (2013-12-31),

13. 8546562 - Substituted porphyrins (2013-10-01),

14. 8399434 - Method of activation of oxazaphosphorines (2013-03-19),

15. 8217026 - Substituted porphyrins (2012-07-10),

Title: Ines Batinic-Haberle: A Trailblazer in Cancer Treatment Innovations

Introduction

Ines Batinic-Haberle is a distinguished inventor based in Durham, NC, who has made substantial contributions to the field of cancer treatment through her innovative research and development. With an impressive portfolio of 25 patents, her work focuses on addressing the side effects associated with radiation and chemotherapy.

Latest Patents

Among her recent patents are methods, compositions, and kits aimed at treating and/or preventing side effects related to radiation and chemotherapy exposure. These inventions include formulations that use active agents at low doses to mitigate tissue damage in patients. Additionally, she has developed fluoro-substituted porphyrin compounds, which involve novel pharmaceutical compositions and methods of preparation and use. These compounds are designed to provide therapeutic options that improve patient outcomes during cancer treatments.

Career Highlights

Ines has held key positions at notable institutions, including Duke University, where she has contributed to significant research initiatives. She has also worked with Aeolus Sciences, Inc., where her innovative ideas have paved the way for advancements in cancer therapies. Her dedication to improving patient care through scientific advancements is evident in her extensive patent portfolio.

Collaborations

Throughout her career, Ines has collaborated with prominent figures in the field, including Irwin Fridovich and James D. Crapo. These partnerships have fostered a rich exchange of knowledge and ideas, enhancing the impact of her research.

Conclusion

Ines Batinic-Haberle is an influential inventor whose work continues to shape the landscape of cancer treatment. Through her numerous patents and collaborations, she exemplifies the essence of innovation in medical science. Her contributions not only enhance therapeutic approaches but also provide hope for patients facing the challenges of cancer treatment.

Profile summary based on public USPTO records.